Join
Live feed
·
PRReleasevia Quantisnow
Scopus BioPharma Inc. logo

Scopus BioPharma Expands Immunotherapy Pipeline with Acquisition of Olimmune

ByQuantisnow·Wall Street's wire, on your screen.
SCPS· Scopus BioPharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SCPS (Scopus BioPharma Inc.) and more on Quantisnow.